GLOW70 Australia

GLOW70 Australia. GLOW70 is the skin and repair blend. Across its three components the research reports more collagen and elastin, firmer and more elastic skin, wounds that close faster and scar less, and quicker repair of tendon and soft tissue. GHK-Cu carries most of the skin quality and hair growth findings. BPC-157 and TB-500 carry the tendon, ligament, muscle and scar remodelling side.

How it does it. Three peptides freeze-dried together in one vial, each working a different way. BPC-157 switches on the growth factor and blood vessel signals tissue uses to rebuild itself. TB-500 controls actin, the internal scaffolding cells rearrange in order to move into a damaged area. GHK-Cu carries copper into cells and switches on genes tied to skin and connective tissue. Three separate repair pathways in one reconstitution.

The vial. Every component is independently HPLC-content-tested by Janoshik before the batch is listed, and the certificate reports each peptide separately rather than as one combined figure. That is research honest, not marketing shorthand. Supplied as a single vial holding BPC-157 10 mg, GHK-Cu 50 mg and TB-500 10 mg, dispatched from Australia, AUD pricing. Reconstituted GLOW70 turns blue, which is the copper in the GHK-Cu and is expected. Supplied strictly for in-vitro and laboratory research use only. Not for human or animal consumption, not a therapeutic good, not TGA-approved.

Also listed as glow peptide. Glow peptide and glow blend are the shorthand names for GLOW70. It is the three-peptide vial combining GHK-Cu, BPC-157 and TB-500, co-lyophilised together rather than reconstituted from three separate vials.

GLOW70 is a formulation rather than a single chemical entity, so it has no single CAS number or molecular weight — each of its three peptides carries its own identity and sits in a distinct research literature. The blend co-presents two soft-tissue-repair peptides with a copper-peptide in one vial.

BPC-157 (a synthetic 15-residue pentadecapeptide) and TB-500 (the research-peptide name for thymosin β-4, the 43-residue G-actin-sequestering peptide) are both referenced across the soft-tissue-repair, wound-healing and angiogenesis research strand — reviewed for BPC-157 by Seiwerth and colleagues (Frontiers in Pharmacology, 2021) and for thymosin β-4 by Goldstein and colleagues (Expert Opinion on Biological Therapy, 2012). GHK-Cu (the copper(II)-complexed tripeptide glycyl-L-histidyl-L-lysine) sits in the copper-peptide / dermal-remodelling research strand, reviewed by Pickart and Margolina (International Journal of Molecular Sciences, 2018).

The research rationale for the blend is to combine these three distinct pathway strands in a single reconstitution; GHK-Cu is the copper-chelate component and gives the reconstituted solution its characteristic blue tint. GLOW70 is the three-peptide healing blend; the related KLOW80 blend adds the melanocortin-derived tripeptide KPV as a fourth component.

Because each of the three peptides is independently HPLC-content-tested, the blend’s certificate reports the measured content of every component rather than a single combined figure. Researchers working with multi-component vials typically record the per-component concentration achieved at reconstitution so each pathway strand can be referenced independently within a protocol.

The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, cosmetic, therapeutic, or human-use claim about this product or any of its components. GLOW70 is not TGA-approved, is not a therapeutic good, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for each component’s pathway data.

Reconstitute the lyophilised GLOW70 vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently — do not shake. The copper-peptide component (GHK-Cu) gives the reconstituted solution a characteristic blue colour, which is expected and a useful batch-consistency marker. Choose a reconstitution volume that suits the per-component concentrations your protocol requires; the per-component content on the certificate of analysis is the canonical reference for the concentration math.

Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificates of analysis published in the lab-reports library.

Shop bacteriostatic water

Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.

30-day returns on unused product in original packaging, with prior approval.